SONOMA PHARMACEUTICALS, INC. Proceeds from Sale of Other Assets
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Proceeds from Sale of Other Assets of $0 for the 12-month period ending 2018-03-31, per its 10-K filed 2018-06-26.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfOtherAssets1 · last filed 2018-06-26
- SONOMA PHARMACEUTICALS, INC. proceeds from sale of other assets for the quarter ending 2017-03-31 was $1.20M.
- SONOMA PHARMACEUTICALS, INC. proceeds from sale of other assets for the quarter ending 2016-03-31 was $0.00.
- SONOMA PHARMACEUTICALS, INC. proceeds from sale of other assets for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- SONOMA PHARMACEUTICALS, INC. proceeds from sale of other assets for fiscal 2017 was $18.64M.
- SONOMA PHARMACEUTICALS, INC. proceeds from sale of other assets for fiscal 2016 was $0.00.
| Period end | Proceeds from Sale of Other Assets 3 month | Proceeds from Sale of Other Assets 9 month | Proceeds from Sale of Other Assets 12 month |
|---|---|---|---|
| 2018-03-31 | $0.00 10-K · filed 2018-06-26 | ||
| 2017-03-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-26 | $18.64M 10-K · filed 2018-06-26 | |
| 2016-12-31 | $17.44M 10-Q · filed 2017-02-17 | ||
| 2016-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-28 | $0.00 10-K · filed 2017-06-28 | |
| 2015-12-31 | $0.00 10-Q · filed 2017-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |